Articles tagged with: ENZ
Enzo Biochem Ready to Reveal EGS21 Data (NYSE:ENZ)
Enzo Biochem Inc (NYSE:ENZ) has announced that their Vice President of Corporate Development, David Goldberg will speak about Company’s extensive oral immune regulation platform at the Windhover TA Partnerships 2009 Conference which will be held …
Enzo Biochem at Bio-Europe 2009 (NYSE:ENZ)
Speaking at the Bio-Europe 2009 Conference in Austria, Enzo Biochem, Inc (NYSE:ENZ) announced that the Company’s therapeutic platforms are utilizing oral immune regulation for immune mediated diseases.
Enzo Biochem NASH Results (NYSE:ENZ)
Enzo Biochem Inc. (NYSE:ENZ) announced today that they have favorable results of the Company’s clinical trial for the treatment of non-alcoholic steatohepatitis.
